English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Page 1 from 16 results
3,4-Dihydrospiro-2H-1,3-benzoxazines and their use in treating edema, abnormal electrolyte retention, and inflammation
Only registered users can translate articles
Log In/Sign up
This invention is concerned with novel 3,4-dihydrospiro-2H-1,3-benzoxazines having therapeutic utility, processes for their preparation, methods of treating inflammation, edema and autoimmune diseases, and novel pharmaceutical formulations comprising at least one of the novel compounds as active
Methods for treatment of kallikrein-related disorders
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The invention relates to methods for treating plasma kallikrein-related disorders, such as diseases or conditions associated with increased vascular permeability or astrocyte activation. Such diseases include diabetic retinopathy, macular edema, intracerebral hemorrhage,
Indolylmaleimide derivatives
Only registered users can translate articles
Log In/Sign up
The present invention relates to indolylmaleimide derivatives, process for their production and pharmaceutical compositions containing them.
More particularly the present invention provides a compound of formula I
##STR00002## wherein R.sub.a is H; CH.sub.3; CH.sub.2--CH.sub.3; or isopropyl, R.sub.b
Indolylmaleimide derivatives
Only registered users can translate articles
Log In/Sign up
The present invention relates to indolylmaleimide derivatives, process for their production and pharmaceutical compositions containing them.
More particularly the present invention provides a compound of formula I
##STR00002## wherein
R.sub.a is H; CH.sub.3; CH.sub.2--CH.sub.3; or isopropyl,
R.sub.b
Indolylmaleimide derivatives
Only registered users can translate articles
Log In/Sign up
The present invention relates to indolylmaleimide derivatives, process for their production and pharmaceutical compositions containing them.
More particularly the present invention provides a compound of formula I
##STR00002## wherein R.sub.a is H; CH.sub.3; CH.sub.2--CH.sub.3; or isopropyl, R.sub.b
Associations of xanthogenates and cyclodextrins, and their use
Only registered users can translate articles
Log In/Sign up
The invention is related to association products of xanthates and their use. The association products can be used for chemical syntheses and the production of pharmaceutical formulations. The formulations are suitable as medicaments. The invention is also related to the use of the medicaments
Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to a novel 3-phenyl-2-pyrazoline derivative or 3-phenyl-tetrahydropyridazine derivative, as well as to a pharmaceutically acceptable salt thereof. More particularly, the present invention relates to an agent containing the above compound, which can
N,N-substituted cyclic amine derivatives
Only registered users can translate articles
Log In/Sign up
INDUSTRIAL FIELD OF THE APPLICATION
The present invention relates to novel N,N-substituted cyclic amine compounds useful as a calcium antagonist, particularly as a nerve-selective calcium antagonist, specifically as an agent for treating and improving the diseases against which an inhibitory action
Methods of treating and preventing diseases and disorders of the central nervous system
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The central nervous system (CNS) of an animal, for example, human, contains several important receptor systems such as the glutamate, acetylcholine, GABA.sub.A, and NMDA receptor systems, and injury to the CNS as well as other diseases and disorders of the CNS could be
Methods of treating and preventing diseases and disorders of the central nervous system
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The central nervous system (CNS) of an animal, for example, human, contains several important receptor systems such as the glutamate, acetylcholine, GABA.sub.A, and NMDA receptor systems, and injury to the CNS as well as other diseases and disorders of the CNS could be
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE TO RELATED APPLICATION
The present invention is based on, and claims priority from 60/008,390, filed Dec. 8, 1995.
BACKGROUND OF THE INVENTION
This application is directed to inhibitors of nitric oxide synthase, and in particular substituted azacycle derivatives.
Nitric Oxide in
Cyclic amidine analogs as inhibitors of nitric oxide synthase
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This application is directed to inhibitors of Nitric oxide synthase, and in particular cyclic amidines.
Nitric Oxide in Biology.
The emergence of nitric oxide (NO), a reactive, inorganic radical gas as a molecule contributing to important physiological and pathological
Aminoadamantane derivatives as therapeutic agents
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et
Aminoadamantane derivatives as therapeutic agents
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et
Aminoadamantane derivatives as therapeutic agents
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Certain adamantane derivatives have been used to treat illnesses. Rimantadine (1-(1-aminoethyl)adamantane) is used for the prophylaxis and treatment of influenza in humans. Amantadine has been used for the treatment of both influenza and Parkinson's disease (Schwab et
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
